Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phosphomannomutase 2 Congenital Disorder of Glycosylation”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableActive Not RecruitingNCT03173300
What this trial is testing

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Who this might be right for
Phosphomannomutase 2 Deficiency
Glycomine, Inc. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06892288
What this trial is testing

Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

Who this might be right for
Phosphomannomutase 2 DeficiencyPMM2-CDG
Glycomine, Inc. 50
Large-scale testing (Phase 3)Ended earlyNCT04925960
What this trial is testing

Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 DeficiencyPhosphomannomutase 2 Congenital Disorder of Glycosylation+2 more
Maggie's Pearl, LLC 42
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06657859
What this trial is testing

Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 Deficiency
Glycomine, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05549219
What this trial is testing

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 Deficiency
Glycomine, Inc. 27